{"id":"W2749602223","doi":"10.1021/acs.molpharmaceut.7b00360","title":"Novel Milrinone Nanoformulation for Use in Cardiovascular Diseases: Preparation and <i>in Vitro</i> Characterization","year":2017,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"Protein Interaction Studies and Fluorescence Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; National Research Council Canada","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Pharmacology; Chemistry; Biocompatibility; Drug delivery; Drug; Doxorubicin; Targeted drug delivery; Medicine; Chemotherapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001483498,0.0001242071,0.0001813457,0.00006464065,0.0001405865,0.0001016197,0.0001013791,0.00007532453,9.935129e-7],"category_scores_gemma":[0.0001032248,0.0001352132,0.0001249453,0.00004641732,0.00004141367,0.00003856875,0.00009109096,0.00005206221,7.86836e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002173932,"about_ca_system_score_gemma":0.00001771137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004281766,"about_ca_topic_score_gemma":0.00002972545,"domain_scores_codex":[0.9991676,0.00002849656,0.0002025787,0.0003183413,0.0001093414,0.000173674],"domain_scores_gemma":[0.9994015,0.000006714152,0.0001076649,0.0003664367,0.00007984696,0.0000378203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003566483,0.00006515736,0.004427873,0.00002564875,0.0001156228,0.000004396425,0.00002243978,0.0005028138,0.988827,0.00001004637,0.0000053947,0.005636995],"study_design_scores_gemma":[0.00207891,0.00004318573,0.02158423,0.00002272741,0.0001376945,0.000006406428,0.00001524562,0.03034507,0.9298869,0.00001436284,0.01562451,0.0002408036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9143395,0.0008966011,0.08396594,0.00009058903,0.00009149595,0.0005253488,0.00006890091,0.000005312702,0.00001626003],"genre_scores_gemma":[0.9972482,0.0007460131,0.001203065,0.0001850481,0.00006278672,0.0001269849,0.0003674491,0.000016008,0.00004449846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0829086,"threshold_uncertainty_score":0.5513833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02681119652535979,"score_gpt":0.3209752873352533,"score_spread":0.2941640908098935,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}